该册标准的实施是藏医药标准体系建设的重要组成部分，不仅系统性扩充了省级藏药材标准数据库，为 藏药研发生产、全过程质量监管及临床合理用药提供了科学统一的技术遵循，更对保护青藏高原独特生 物资源、保障群众用药安全、增强"青海藏药"品牌影响力具有深远意义。 本报讯 （记者 郭靓） 1月6日，青海省药品监督管理局传来消息，为提升藏药材质量安全水平，推动青 海藏医药产业高质量发展，省药品监督管理局在完成《青海省藏药材标准》第一、二册编制工作的基础 上，持续深化标准体系建设，正式出版发行《青海省藏药材标准》第三册，助力中藏医药传承创新发 展。 《青海省藏药材标准》第三册收载藏药材标准的制修订工作由省药品检验检测院牵头，联合中国科学院 西北高原生物研究所、省藏医院、青海民族大学等多家科研院所共同完成。该册共收载藏药材26种，主 要为我省藏医医疗机构临床常用、本省特色资源丰富且现行国家药品标准尚未收载的品种。标准内容涵 盖药材的名称（藏文名、中文名、拉丁名）、来源、性状、鉴别、检查、浸出物、含量测定、炮制方 法、性味与功效（功能与主治）、用法用量、贮藏等各项质量控制指标与研究数据。编制过程中，工作 组强化了药材的安全性、有效 ...

12月21日，恰逢冬至节气，由青海省卫生健康委员会主办的"2025年度青海省非物质文化遗产'巴桑曼玛'文化 体验日"活动在西宁市城东区中惠万达广场举行。活动以"传承藏医药瑰宝 乐享非遗康养生活"为主题，通过 非遗展示、健康讲座、义诊体验、文化展演等多种形式，为市民带来一场沉浸式的藏医药文化盛宴。 青海省藏医院院长东雷表示，青海省藏医院作为藏医药事业的传承与发展主力，始终坚持以人民健康为中 心，推动藏医药文化活态传承。本次活动是藏医药走进现代生活、服务大众健康的一次生动实践，旨在让更 多人了解、信任并受益于藏医药。 青海省卫生健康委党组成员、副主任端智表示，藏医药是中华民族传统医药的重要组成部分，"巴桑曼玛"作 为省级非物质文化遗产，承载着深厚的健康文化与"治未病"智慧。近年来，青海省委、省政府高度重视中 （藏）医药发展，将其纳入健康青海建设总体布局。希望通过"非遗+健康+文旅"等创新模式，让藏医药在预 防、康复、养生等领域发挥更大作用，更好地满足人民群众的健康需求。 在"养生大讲堂"环节，青海省藏医院康养基地卓玛加围绕"藏医冬季康养"主题开展健康讲座，并与市民互动 问答，现场气氛热烈。活动尾声，医护人员现场带 ...

本报讯 （记者 郭靓） 记者近日从青海省藏医药标准化工作会议获悉，我省藏医药发展环境逐步优化， 藏医药标准化进程不断加快，初步建立国家标准引领、行业标准支撑、地方标准细化、团体标准补充的 协同互补体系架构。截至目前，我省累计制定发布中（藏）医相关地方标准86项，牵头制定团体标准、 行业标准28项，助力藏医药传承创新发展。 在国家中医药管理局指导和兄弟省份支持下，省内科技、农业农村、林草、市场监管、药监、卫健、医 保等部门协同联动，通过政策赋能、平台搭建、力量聚合，携手在藏医药资源保护、标准制定监管、产 业质量规范等方面同向发力，推动藏医药标准化工作从"零散探索"迈向"系统推进"的新阶段，各项工作 取得多维度突破。政策层面，我省出台《青海省中医药条例》《青海省"十四五"中藏医药发展规划》 等，将标准化要求融入临床服务和产业发展全流程，玉树藏族自治州、果洛藏族自治州同步出台藏医药 发展地方条例。 标准制定层面，先后填补藏医护理、病历书写等省内空白。制定的《青海省藏药"佐太"及其原辅料质量 标准和炮制规范》等，为藏药规范生产、质量控制和安全有效提供了技术支撑。联合四川、云南、西 藏、甘肃等省区制定的《藏医疾病分类与 ...

Core Points - The Tibet Autonomous Region has successfully entered 1,613 first-class prescription information into the "Chinese Tibetan Medicine Resource Database," laying a solid foundation for the protection of Tibetan medicine resources [1][2] - The Tibet Drug Administration is advancing high-quality development in the industry by revising the "95 Tibetan Medicine Standards" and has submitted quality standard revision drafts for 14 varieties to the National Medical Products Administration [1][2] - A total of 80 varieties have been submitted for approval, with 11 varieties already approved, and 44 varieties of standards research have been completed under the "Second Batch of Tibetan Medicine Standards Three-Year Action Plan" [1][2] - The region is actively promoting the development and utilization of Tibetan medicinal materials, having published the first batch of 9 processing varieties and guidelines [1][2] - The Tibet Drug Administration has also conducted the 2025 Tibetan Medicine Practitioner Qualification Examination, with 1,331 participants, receiving widespread recognition [1][2] - The development of the second phase of the smart drug supervision platform has been completed, enhancing the level of drug regulation and achieving seamless integration with national and regional public service systems [2] - The administration has developed technical standards for Tibetan medical devices, leading to the clinical use of five specialized medical devices, which have received positive feedback from Tibetan medical institutions and patients [2]

Core Insights - The economic development of Tibet has achieved historic milestones over the past 60 years, with GDP increasing from 327 million yuan in 1965 to 276.5 billion yuan in 2024, emphasizing the need for high-quality development based on local realities [1] - The core of Tibet's economy lies in its real economy, which has been shaped by its unique geographical and environmental conditions, leading to the establishment of a nine-industry system that includes highland agriculture, clean energy, green industry, digital technology, cultural tourism, modern services, Tibetan medicine, border trade logistics, and general aviation [1] - The real economy serves as a stabilizer for improving livelihoods, a cornerstone for social stability, and a vital link for promoting prosperity in border areas, while also playing a crucial role in poverty alleviation and cultural heritage [2] Industry Development - The focus on enhancing the quality and efficiency of the real economy is essential for sustainable development, as it acts as a guardian of ecological security and a driver for common prosperity [2] - The shift from reliance on policy support to a sustainable market-driven model is underway, with technological innovation and industrial upgrades becoming the core engines for continuous economic health [3] - The development strategy includes fostering local endogenous power through the modernization of highland agriculture, industrialization of clean energy, and integration of culture and tourism, which collectively aim to upgrade the characteristic industrial system [3] Strategic Initiatives - The emphasis on local enterprise growth and the development of the private economy is crucial for stimulating operational vitality [3] - The integration of technology into traditional industries and the innovation of the digital economy are key to enhancing industrial competitiveness [3] - The construction of the South Asia transit hub and the deepening of the Belt and Road Initiative are expected to unlock the potential for openness and connectivity [3]

Core Insights - The economic development of Tibet has achieved historic milestones, with GDP increasing from 327 million in 1965 to 276.5 billion in 2024, emphasizing the need for high-quality development based on local realities [1] Group 1: Economic Structure - The core of Tibet's economy lies in the real economy, which has evolved under harsh natural conditions, forming a unique industrial system comprising nine key sectors: highland特色 agriculture, clean energy, green industry, high-tech digital, cultural tourism, modern services, Tibetan medicine, border trade logistics, and general aviation [1] - These sectors are not only vital for regional economic development but also serve as a foundation for social stability, ethnic unity, and ecological protection [1] Group 2: Role of the Real Economy - The real economy acts as a stabilizer for improving livelihoods, a cornerstone for social stability, and a crucial link for promoting prosperity in border areas [2] - It possesses "green genes," safeguarding ecological security, and is a driving force for common prosperity, supporting poverty alleviation and rural revitalization efforts [2] - The real economy also plays a significant role in the transmission and innovation of ethnic culture, injecting new life and economic value into traditional handicrafts like Thangka, Tibetan carpets, and incense through industrial development [2] Group 3: Internal Development Dynamics - Tibet's development is shifting from reliance on "policy blood transfusions" to a sustainable "market blood production" model, with technological innovation and industrial upgrading as core engines for continuous economic health [3] - The focus is on cultivating local endogenous power through the modernization of highland green agriculture, industrialization of clean energy, and enhancement of cultural tourism [3] - The strategy includes leveraging local enterprises and private sector growth, enhancing industry competitiveness through technology, and optimizing human resource structures via local talent development [3] - This approach aims to effectively connect the "resources-industry-market" chain, promoting high-quality economic development in Tibet [3]

Core Viewpoint - The 14th National Tibetan Medicine Advanced Training Course aims to enhance the professional capabilities of Tibetan medicine practitioners and promote the academic inheritance and innovative development of Tibetan medicine [1] Group 1: Event Overview - The training course is hosted by the China Tibetology Research Center and co-organized by various institutions including the Tibetan Medicine Research Institute and Beijing Tibetan Hospital [1] - The theme of this year's training is "Tibetan Medical Classics and Clinical Experience," with over 100 participants from regions such as Tibet, Sichuan, Qinghai, Gansu, Yunnan, and Beijing attending a 7-day systematic training [1] Group 2: Significance and Impact - Tibetan medicine is highlighted as an important part of traditional Chinese medicine, characterized by its long history and unique theoretical system, regarded as a precious treasure in the Chinese medical heritage [1] - The continuous hosting of the National Tibetan Medicine Advanced Training Course provides a high-level platform for learning and exchange among Tibetan medicine practitioners, facilitating knowledge sharing and experience dissemination [1] - This initiative significantly contributes to the construction of a professional talent team in Tibetan medicine and the comprehensive development of the discipline, helping Tibetan medicine to keep pace with the times [1]

Core Viewpoint - The strategic investment in Xizang Ganlu Tibetan Medicine Co., Ltd. marks a significant step towards achieving the company's listing goals and aligns with the regional "Galsang Flower Action" plan [1][4]. Group 1: Strategic Investors - The strategic investors include a powerful lineup, such as the State-owned Enterprise Mixed Ownership Reform Fund, which is a national-level fund initiated by the State-owned Assets Supervision and Administration Commission [3]. - Other investors include Guangzhou Pharmaceutical Holdings, a Fortune Global 500 company focused on traditional Chinese medicine, and Chengdu Wufang Industrial Equity Investment Fund, which has a total scale exceeding 44 billion [3]. - Xizang Trust, a financial institution controlled by the Tibet Autonomous Region Finance Department, has established long-term partnerships with over 100 listed companies [3]. Group 2: Investment Purpose and Impact - The investment of approximately 174 million will leverage the strengths of strategic shareholders in capital, industry, channels, and management to enhance the company's core competitiveness [4]. - The company aims to expand its production capacity, improve its industrial chain, protect its brand, and enhance market expansion efforts [4]. - The focus is on domestic market development, particularly targeting major markets in Beijing, the Yangtze River Delta, and Southwest China, to establish a solid foundation for the national expansion of Tibetan medicine [5].

Core Insights - The strategic investment initiative by Gansu Tibetan Medicine Co., Ltd. marks a significant step towards achieving its listing goals and implementing the "Galsang Flower Action" plan [1] Group 1: Investment and Strategic Partnerships - Gansu Tibetan Medicine successfully introduced four strong strategic investors, reflecting the market's high recognition of the company's future development potential [1] - The company aims to raise approximately 174 million yuan through this fundraising, leveraging the advantages of strategic shareholders in capital, industry, channels, and management to enhance its core competitiveness [1] - The strategic investors include a national-level fund focused on mixed-ownership reform, a private equity fund affiliated with Guangzhou Pharmaceutical Group, a local government-backed private equity fund in Chengdu, and a financial institution controlled by the Tibet Autonomous Region [2] Group 2: Market Expansion and Development Strategy - Gansu Tibetan Medicine is focusing on expanding its presence in mainland markets, particularly targeting Beijing, the Yangtze River Delta, and Southwest regions for future market development [1] - The collaboration with capable partners is expected to lay a solid foundation for the strategic development of Tibetan medicine across the nation [1] - The strategic investors expressed confidence in the company's growth prospects and plan to actively participate in governance and strategic planning to enhance market competitiveness [3]

Core Insights - The strategic investment initiative by Gansu Tibetan Medicine Co., Ltd. has successfully raised approximately 174 million yuan through the introduction of four strategic investors, marking a significant milestone in the company's listing process [1][3]. Group 1: Strategic Investors - The strategic investors include a national-level fund, a Fortune 500 pharmaceutical state-owned enterprise, a local state-owned investment platform, and financial institutions, collectively referred to as the "strategic investment team" [1][2]. - The national-level fund involved is the Mixed Ownership Reform Fund, which is managed by China Chengtong Holdings Group and has an initial scale of 70.7 billion yuan, focusing on sectors such as healthcare and biopharmaceuticals [1][2]. Group 2: Future Development Plans - The company aims to leverage the strengths of its strategic investors in capital, industry, channels, and management to enhance its core competitiveness and promote high-quality development [3]. - The strategic investors were selected based on their ability to support the company's goal of expanding into mainland markets, particularly targeting Beijing, the Yangtze River Delta, and the Southwest regions [3].